PortViewPortView
Insmed logo

Insmed (INSM) Stock Analysis

NASDAQHealthcareBiotechnology

$124.36+2.35%
1-year price historyRange $91.88 – $211.41
52-week range$124.36
$90.39$212.75

What Insmed does

Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.

Key metrics

Market cap
$26.96B
P/E (TTM)
-30.26
EPS (TTM)
$-4.11
Beta
0.79
Dividend yield
0.00%
Revenue / share
$5.23
50-day avg
$114.30
200-day avg
$141.83
52-week high
$212.75
52-week low
$90.39
CEO
William H. Lewis

ETFs linked to INSM

Broad-market and Healthcare sector ETFs an investor holding Insmed is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how INSM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INSM in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Insmed?
Insmed trades under the ticker INSM on NASDAQ.
Which exchange is INSM listed on?
INSM is listed on NASDAQ.
What sector does Insmed operate in?
Insmed is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze INSM in a portfolio?
PortView shows INSM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.